3D medicine
3D Medicine, also known as 3D Med, is a pioneering company headquartered in the United States, with significant operations across North America and Europe. Founded in 2015, the company has rapidly established itself within the healthcare industry, focusing on advanced 3D printing technologies for medical applications. Specialising in custom medical devices, surgical planning tools, and patient-specific anatomical models, 3D Medicine stands out for its commitment to precision and innovation. The company has achieved notable milestones, including collaborations with leading hospitals and research institutions, enhancing surgical outcomes and patient care. With a strong market position, 3D Medicine continues to lead the way in transforming healthcare through cutting-edge technology, making significant contributions to personalised medicine and surgical efficiency.
DitchCarbon Score
How does 3D medicine's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
3D medicine's score of 13 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
3D medicine's reported carbon emissions
In 2023, 3D Medicine reported total carbon emissions of approximately 4,200,280 kg CO2e, comprising 412,850 kg CO2e from Scope 1, 3,087,610 kg CO2e from Scope 2, and 3,746,820 kg CO2e from Scope 3 emissions. This marks a significant increase in Scope 1 emissions compared to previous years, where Scope 1 emissions were zero in 2021 and 3,087,610 kg CO2e in 2022. In 2022, the company had total emissions of about 4,200,440 kg CO2e, with Scope 1 emissions at 3,087,610 kg CO2e and Scope 2 emissions at 659,210 kg CO2e. The 2021 emissions were notably lower, with total emissions of approximately 715,340 kg CO2e, consisting of 357,670 kg CO2e from both Scope 2 and Scope 3. Despite these figures, 3D Medicine has not disclosed any specific reduction targets or climate pledges, indicating a lack of formal commitments to reduce their carbon footprint. The absence of documented reduction initiatives suggests that the company may need to enhance its climate strategy to align with industry standards and expectations for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 3,087,610 | - | 0,000,000 | 000,000 |
| Scope 2 | 659,210 | 000,000 | 000,000 | 0,000,000 |
| Scope 3 | 3,746,820 | 000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
3D medicine is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
